These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 29452547)

  • 1. Potential value of circulating microRNA-126 and microRNA-210 as biomarkers for type 2 diabetes with coronary artery disease.
    Amr KS; Abdelmawgoud H; Ali ZY; Shehata S; Raslan HM
    Br J Biomed Sci; 2018 Apr; 75(2):82-87. PubMed ID: 29452547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating endothelium-enriched microRNA-126 as a potential biomarker for coronary artery disease in type 2 diabetes mellitus patients.
    Al-Kafaji G; Al-Mahroos G; Abdulla Al-Muhtaresh H; Sabry MA; Abdul Razzak R; Salem AH
    Biomarkers; 2017; 22(3-4):268-278. PubMed ID: 27321479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of Circulating Cardiomyocyte-Enriched miR-1 and miR-133 Associate with the Risk of Coronary Artery Disease in Type 2 Diabetes Patients and Serve as Potential Biomarkers.
    Al-Muhtaresh HA; Salem AH; Al-Kafaji G
    J Cardiovasc Transl Res; 2019 Aug; 12(4):347-357. PubMed ID: 30610670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating MicroRNA-423-3p Improves the Prediction of Coronary Artery Disease in a General Population　- Six-Year Follow-up Results From the China-Cardiovascular Disease Study.
    Wang X; Dong Y; Fang T; Wang X; Chen L; Zheng C; Kang Y; Jiang L; You X; Gai S; Wang Z; Cao H
    Circ J; 2020 Jun; 84(7):1155-1162. PubMed ID: 32404537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating miRNA-33: a potential biomarker in patients with coronary artery disease.
    Reddy LL; Shah SAV; Ponde CK; Rajani RM; Ashavaid TF
    Biomarkers; 2019 Feb; 24(1):36-42. PubMed ID: 30022694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating miR-130 and its target PPAR-γ may be potential biomarkers in patients of coronary artery disease with type 2 diabetes mellitus.
    Yuan Y; Peng W; Liu Y; Xu Z
    Mol Genet Genomic Med; 2019 Sep; 7(9):e909. PubMed ID: 31368668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNA-378 levels serve as a novel biomarker for assessing the severity of coronary stenosis in patients with coronary artery disease.
    Li H; Gao F; Wang X; Wu J; Lu K; Liu M; Li R; Ding L; Wang R
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31064817
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulatory miR-133b and miR-21 as Novel Biomarkers in Early Prediction and Diagnosis of Coronary Artery Disease.
    Kumar D; Narang R; Sreenivas V; Rastogi V; Bhatia J; Saluja D; Srivastava K
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32033332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review of microRNA biomarkers in acute coronary syndrome and stable coronary artery disease.
    Kaur A; Mackin ST; Schlosser K; Wong FL; Elharram M; Delles C; Stewart DJ; Dayan N; Landry T; Pilote L
    Cardiovasc Res; 2020 May; 116(6):1113-1124. PubMed ID: 31782762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Plasma MiRNA-204 and the Presence and Severity of Coronary Artery Calcification in Patients With Type 2 Diabetes.
    Ding YD; Pei YQ; Rui-Wang ; Yang JX; Zhao YX; Liu XL; Shen H; Ma Q; Zhang S; Ge HL
    Angiology; 2021 May; 72(5):451-458. PubMed ID: 33401931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Extracellular miRNA Analysis in Patients with Stable CAD and Acute Coronary Syndromes.
    Zhelankin AV; Stonogina DA; Vasiliev SV; Babalyan KA; Sharova EI; Doludin YV; Shchekochikhin DY; Generozov EV; Akselrod AS
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma MicroRNA-126-5p is Associated with the Complexity and Severity of Coronary Artery Disease in Patients with Stable Angina Pectoris.
    Li HY; Zhao X; Liu YZ; Meng Z; Wang D; Yang F; Shi QW
    Cell Physiol Biochem; 2016; 39(3):837-46. PubMed ID: 27497911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of circulating pro-angiogenic microRNA expressions as biomarkers for rapid angiographic stenotic progression and restenosis risks in coronary artery disease patients underwent percutaneous coronary intervention.
    Dai R; Liu Y; Zhou Y; Xiong X; Zhou W; Li W; Zhou W; Chen M
    J Clin Lab Anal; 2020 Jan; 34(1):e23013. PubMed ID: 31495986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNAs as predictive biomarkers of coronary artery diseases in type 2 diabetes patients.
    Mahjoob G; Ahmadi Y; Fatima Rajani H; Khanbabaei N; Abolhasani S
    J Clin Lab Anal; 2022 May; 36(5):e24380. PubMed ID: 35349731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating MicroRNAs as Novel Diagnostic Biomarkers for Very Early-onset (≤40 years) Coronary Artery Disease.
    DU Y; Yang SH; Li S; Cui CJ; Zhang Y; Zhu CG; Guo YL; Wu NQ; Gao Y; Sun J; Dong Q; Liu G; Li JJ
    Biomed Environ Sci; 2016 Aug; 29(8):545-554. PubMed ID: 27660218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Toll-like receptor 4-responsive microRNA panel in patients with coronary artery disease: results from prospective and randomized study of treatment with renin-angiotensin system blockade.
    Satoh M; Takahashi Y; Tabuchi T; Tamada M; Takahashi K; Itoh T; Morino Y; Nakamura M
    Clin Sci (Lond); 2015 Apr; 128(8):483-91. PubMed ID: 25385173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miR-106a may Function as Potential Biomarkers in Patients with Coronary Artery Disease.
    Ding H; Hu CX; Xu JK
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNA-126 &122 in patients with coronary artery disease: Correlation with small dense LDL.
    Mishra S; Rizvi A; Pradhan A; Perrone MA; Ali W
    Prostaglandins Other Lipid Mediat; 2021 Apr; 153():106536. PubMed ID: 33556577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers.
    Pescador N; Pérez-Barba M; Ibarra JM; Corbatón A; Martínez-Larrad MT; Serrano-Ríos M
    PLoS One; 2013; 8(10):e77251. PubMed ID: 24204780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of circulating microRNAs as diagnostic biomarkers for coronary artery disease.
    Zhang L; Zhang Y; Xue S; Ding H; Wang Y; Qi H; Wang Y; Zhu W; Li P
    J Cell Mol Med; 2020 Jan; 24(1):1146-1150. PubMed ID: 31709737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.